LBRX vs MELI · $803.4M cap vs P/E 43, rev $19.01B
LB Pharmaceuticals Inc Common Stock (LBRX) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
LBRX does not have a complete income-statement cache yet.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
LBRX currently screens at market cap $803.4M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the LBRX and MELI stock pages for the full models.
Not investment advice.